Merck: Keytruda's Sales Projections Outweigh Competitive And Patent Risks
Merck's undervalued stock presents growth opportunities with Keytruda and promising pipeline drugs, making it a Buy despite ...
verywellhealth8d
8 Vitamins and Supplements for Crohn’s Disease
Vitamins and mineral supplements can help address nutritional deficiencies that commonly affect people who have Crohn’s disease. Here's what your doctor may recommend.
Reuters23d
Merck buys cancer therapy developer Modifi Biosciences for up to $1.3 bln
Oct 23 (Reuters) - Merck (MRK.N), opens new tab has acquired Modifi Biosciences for as much as $1.3 billion, gaining access to its experimental cancer therapies, the privately held biotech firm ...
FierceBiotech23d
Merck sets sights on brain cancer with $30M Modifi acquisition
Merck & Co. is putting down $30 million upfront ... TMZ is used when the cancer cells have a nonfunctional version of the DNA repair protein called O6-methylguanine methyltransferase (MGMT ...
Yahoo Finance23d
Merck buys cancer therapy developer Modifi Biosciences for up to $1.3 billion
(Reuters) - Merck has acquired Modifi Biosciences for as much as $1.3 billion, gaining access to its experimental cancer therapies, the privately held biotech firm said on Wednesday. As part of ...
Yahoo Finance25d
Merck Stock Down More Than 14% in 6 Months: Buy, Sell or Hold?
Merck’s MRK stock has declined 14.4% in the past six months against an increase of 9.7% for the Large Cap Pharmaceuticals industry. The stock has also underperformed the sector and the S&P 500 ...
Business Wire27d
Gilead and Merck Announce Phase 2 Data Showing a Treatment Switch to an Investigational Oral Once-Weekly Combination Regimen of Islatravir and Lenacapavir Maintained Viral ...
FOSTER CITY, Calif., & RAHWAY, N.J.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced new results ...
FierceBiotech28d
With trial win, Merck's RSV antibody clesrovimab looks poised to take on Sanofi and AZ's Beyfortus
Three months after revealing that its respiratory syncytial virus (RSV) preventive antibody clesrovimab had passed muster in a phase 2b/3 trial, Merck is putting numbers to the claim. Clesrovimab ...
Bloomberg L.P.29d
Merck KGaA Sees Post-Covid Life Sciences Rebound, Eyes M&A
Merck KGaA said it’s seeing the beginning of a post-Covid pandemic rebound in life sciences as it reaffirmed the group’s sales and profit guidance for the full year. The German science and ...
Reuters29d
Merck's RSV antibody for infants effective in reducing some types of infections in study
Oct 17 (Reuters) - (This Oct. 17 story has been corrected to say that the drug reduced some types of respiratory infection, not all, in the headline and paragraphs 1 and 2) Merck (MRK.N), opens ...
9to5Mac29d
New iPad mini 7 seems to have a binned version of the A17 Pro chip
the A17 Pro chip has a 6-core CPU and a 6-core GPU, as well as 8GB of RAM. While the chip in the iPad most likely also has 8GB of RAM, Apple’s website suggests that it uses a binned version of ...